Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC : A Multi-Institutional Analysis of the US HIPEC Collaborative
BACKGROUND: Postoperative complications (POCs) are associated with worse oncologic outcomes in various cancer histologies. The impact of POCs on the survival of patients with appendiceal or colorectal cancer after cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) is unknown.
METHODS: The US HIPEC Collaborative (2000-2017) was reviewed for patients who underwent CCR0/1 CRS/HIPEC for appendiceal/colorectal cancer. The analysis was stratified by noninvasive appendiceal neoplasm versus invasive appendiceal/colorectal adenocarcinoma. The POCs were grouped into infectious, cardiopulmonary, thromboembolic, and intestinal dysmotility. The primary outcomes were overall survival (OS) and recurrence-free survival (RFS).
RESULTS: Of the 1304 patients, 33% had noninvasive appendiceal neoplasm (n = 426), and 67% had invasive appendiceal/colorectal adenocarcinoma (n = 878). In the noninvasive appendiceal cohort, POCs were identified in 55% of the patients (n = 233). The 3-year OS and RFS did not differ between the patients who experienced a complication and those who did not (OS, 94% vs 94%, p = 0.26; RFS, 68% vs 60%, p = 0.15). In the invasive appendiceal/colorectal adenocarcinoma cohort, however, POCs (63%; n = 555) were associated with decreased 3-year OS (59% vs 74%; p < 0.001) and RFS (32% vs 42%; p < 0.001). Infectious POCs were the most common (35%; n = 196). In Multivariable analysis accounting for gender, peritoneal cancer index (PCI), and incomplete resection (CCR1), infectious POCs in particular were associated with decreased OS compared with no complication (hazard ratio [HR] 2.08; p < 0.01) or other types of complications (HR, 1.6; p < 0.01). Similarly, infectious POCs were independently associated with worse RFS (HR 1.61; p < 0.01).
CONCLUSION: Postoperative complications are associated with decreased OS and RFS after CRS/HIPEC for invasive histology, but not for an indolent disease such as noninvasive appendiceal neoplasm, and this association is largely driven by infectious complications. The exact mechanism is unknown, but may be immunologic. Efforts must target best practices and standardized prevention strategies to minimize infectious postoperative complications.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
|---|---|
| Enthalten in: |
Annals of surgical oncology - 27(2020), 13 vom: 16. Dez., Seite 4980-4995 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gamboa, Adriana C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 05.05.2021 Date Revised 03.12.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1245/s10434-020-08843-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM31272490X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31272490X | ||
| 003 | DE-627 | ||
| 005 | 20231225145030.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1245/s10434-020-08843-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1042.xml |
| 035 | |a (DE-627)NLM31272490X | ||
| 035 | |a (NLM)32696303 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gamboa, Adriana C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC |b A Multi-Institutional Analysis of the US HIPEC Collaborative |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.05.2021 | ||
| 500 | |a Date Revised 03.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Postoperative complications (POCs) are associated with worse oncologic outcomes in various cancer histologies. The impact of POCs on the survival of patients with appendiceal or colorectal cancer after cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) is unknown | ||
| 520 | |a METHODS: The US HIPEC Collaborative (2000-2017) was reviewed for patients who underwent CCR0/1 CRS/HIPEC for appendiceal/colorectal cancer. The analysis was stratified by noninvasive appendiceal neoplasm versus invasive appendiceal/colorectal adenocarcinoma. The POCs were grouped into infectious, cardiopulmonary, thromboembolic, and intestinal dysmotility. The primary outcomes were overall survival (OS) and recurrence-free survival (RFS) | ||
| 520 | |a RESULTS: Of the 1304 patients, 33% had noninvasive appendiceal neoplasm (n = 426), and 67% had invasive appendiceal/colorectal adenocarcinoma (n = 878). In the noninvasive appendiceal cohort, POCs were identified in 55% of the patients (n = 233). The 3-year OS and RFS did not differ between the patients who experienced a complication and those who did not (OS, 94% vs 94%, p = 0.26; RFS, 68% vs 60%, p = 0.15). In the invasive appendiceal/colorectal adenocarcinoma cohort, however, POCs (63%; n = 555) were associated with decreased 3-year OS (59% vs 74%; p < 0.001) and RFS (32% vs 42%; p < 0.001). Infectious POCs were the most common (35%; n = 196). In Multivariable analysis accounting for gender, peritoneal cancer index (PCI), and incomplete resection (CCR1), infectious POCs in particular were associated with decreased OS compared with no complication (hazard ratio [HR] 2.08; p < 0.01) or other types of complications (HR, 1.6; p < 0.01). Similarly, infectious POCs were independently associated with worse RFS (HR 1.61; p < 0.01) | ||
| 520 | |a CONCLUSION: Postoperative complications are associated with decreased OS and RFS after CRS/HIPEC for invasive histology, but not for an indolent disease such as noninvasive appendiceal neoplasm, and this association is largely driven by infectious complications. The exact mechanism is unknown, but may be immunologic. Efforts must target best practices and standardized prevention strategies to minimize infectious postoperative complications | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Lee, Rachel M |e verfasserin |4 aut | |
| 700 | 1 | |a Turgeon, Michael K |e verfasserin |4 aut | |
| 700 | 1 | |a Zaidi, Mohammad Y |e verfasserin |4 aut | |
| 700 | 1 | |a Kimbrough, Charles W |e verfasserin |4 aut | |
| 700 | 1 | |a Grotz, Travis E |e verfasserin |4 aut | |
| 700 | 1 | |a Leiting, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Fournier, Keith |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Andrew J |e verfasserin |4 aut | |
| 700 | 1 | |a Dineen, Sean P |e verfasserin |4 aut | |
| 700 | 1 | |a Powers, Benjamin D |e verfasserin |4 aut | |
| 700 | 1 | |a Veerapong, Jula |e verfasserin |4 aut | |
| 700 | 1 | |a Baumgartner, Joel M |e verfasserin |4 aut | |
| 700 | 1 | |a Clarke, Callisia N |e verfasserin |4 aut | |
| 700 | 1 | |a Mogal, Harveshp |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Sameer H |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Tiffany C |e verfasserin |4 aut | |
| 700 | 1 | |a Lambert, Laura A |e verfasserin |4 aut | |
| 700 | 1 | |a Hendrix, Ryan J |e verfasserin |4 aut | |
| 700 | 1 | |a Abbott, Daniel E |e verfasserin |4 aut | |
| 700 | 1 | |a Pokrzywa, Courtney |e verfasserin |4 aut | |
| 700 | 1 | |a Raoof, Mustafa |e verfasserin |4 aut | |
| 700 | 1 | |a Eng, Oliver S |e verfasserin |4 aut | |
| 700 | 1 | |a Johnston, Fabian M |e verfasserin |4 aut | |
| 700 | 1 | |a Greer, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Cloyd, Jordan M |e verfasserin |4 aut | |
| 700 | 1 | |a Maithel, Shishir K |e verfasserin |4 aut | |
| 700 | 1 | |a Staley, Charles A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of surgical oncology |d 1995 |g 27(2020), 13 vom: 16. Dez., Seite 4980-4995 |w (DE-627)NLM074734997 |x 1534-4681 |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2020 |g number:13 |g day:16 |g month:12 |g pages:4980-4995 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1245/s10434-020-08843-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2020 |e 13 |b 16 |c 12 |h 4980-4995 | ||